Similarly, variations in microbiome composition have been linked to different breast cancer molecular subtypes, including estrogen receptor-positive (ER+), triple-negative breast cancer (TNBC), and HER2-positive subtypes [121,124,125]. This evidence concerns the gene ERBB2 and breast cancer.